journal article·2024-04

A Versatile Passivated Protein‐Adsorption Platform for Rapid Healing of Vascular Stents by Modulating the Microenvironment

Linhua Li, Zhengjiang Cao, Chunle Zhang, Li Li, Qingying Li, Chang Liu, Chao Qu, Rifang Luo, Ping Fu, Yunbing Wang

Advanced Functional Materials· Volume 34· Issue 16
Publisher page

Abstract

Abstract Biodegradable stents have paved the way to treat coronary artery disease. However, rapid reendothelialization is required to solve the problems of mismatched degradation rates, localized inflammation, and insufficient biocompatibility. Herein, a novel passivated protein‐adsorption coating is synthesized by coordination chelation, oxidation, cross‐linking, polymerization, and deposition of dopamine, (‐)‐epigallocatechin gallate (EGCG), and copper ions (Cu2+) using two‐electron oxidation. This coating exhibits hierarchical functionality, that is, at the macroscale, its superhydrophilicity conveys antifouling ability; whereas at the microscale, the active groups (quinone‐, amino‐, hydroxyphenyl groups and aromatic ring) facilitate protein adsorption. Antifouling ability prevents acute thrombosis and inflammation and maintains initial microenvironment stability post‐implantation. The active groups facilitate gradual endothelial cells (ECs) adhesion. Meanwhile, the decomposition of nitric oxide (NO) donors to release NO is catalyzed by Cu2+, and EGCG alleviates or prevents oxidative stress damage, inflammatory responses, thrombosis formation, and excessive smooth muscle cells proliferation in the stent microenvironment. This provides favorable conditions for the rapid and healthy growth of ECs. This study proposes a novel strategy for rapid neointima formation comprising healthy ECs on the surfaces of biodegradable stents by depositing a passivated protein‐adsorption coating (polydopamine/EGCG/Cu), opening new possibilities for the efficient treatment of coronary artery disease.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Coronary Interventions and Diagnostics · Electrospun Nanofibers in Biomedical Applications · Peripheral Artery Disease Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Kidney Research Institute, Division of Nephrology West China Hospital of Sichuan University Chengdu 610041 China

Institute of Clinical Pathology West China Hospital of Sichuan University Chengdu 610041 China

Department of Ophthalmology, Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu 611731 China

National Engineering Research Center for Biomaterials Sichuan University Chengdu 610064 China

Funding

National Key Research and Development Program of China · Key Research and Development Program of Sichuan Province · China Postdoctoral Science Foundation

References (54)

Show source-provided references
1. 10.1021/acs.est.3c0207610.1021/acs.est.3c02076 ↗
2. 10.1016/j.jacc.2021.12.01710.1016/j.jacc.2021.12.017 ↗
3. 10.1056/NEJMoa160799110.1056/NEJMoa1607991 ↗
4. 10.1016/j.jacc.2017.12.03210.1016/j.jacc.2017.12.032 ↗
5. 10.1093/cvr/cvy09710.1093/cvr/cvy097 ↗
6. 10.1016/j.matt.2022.05.01810.1016/j.matt.2022.05.018 ↗
7. 10.1002/adfm.20210825610.1002/adfm.202108256 ↗
8. 10.1002/adfm.20200722610.1002/adfm.202007226 ↗
9. 10.1002/adfm.20190933110.1002/adfm.201909331 ↗
10. 10.1038/s41573-021-00198-110.1038/s41573-021-00198-1 ↗
11. 10.1016/j.atherosclerosis.2020.07.02710.1016/j.atherosclerosis.2020.07.027 ↗
12. 10.1039/D1TB01617B10.1039/D1TB01617B ↗
13. 10.1038/s41467-018-07495-110.1038/s41467-018-07495-1 ↗
14. 10.1016/j.bioactmat.2019.12.00810.1016/j.bioactmat.2019.12.008 ↗
15. 10.1016/j.cis.2023.10294810.1016/j.cis.2023.102948 ↗
16. Z.He N.Wang X.Yang L.Mu Z.Wang J.Su M.Luo J.Li F.Deng X.Lan 2023 12.10.1515/ntrev-2022-0552 ↗
17. 10.1002/anie.20140991110.1002/anie.201409911 ↗
18. 10.1016/j.cej.2020.12619610.1016/j.cej.2020.126196 ↗
19. 10.1021/acsnano.2c0568210.1021/acsnano.2c05682 ↗
20. 10.1016/j.cis.2020.10214110.1016/j.cis.2020.102141 ↗
21. 10.1016/j.porgcoat.2021.10628510.1016/j.porgcoat.2021.106285 ↗
22. 10.1016/j.redox.2020.10148710.1016/j.redox.2020.101487 ↗
23. 10.1002/anie.20221098010.1002/anie.202210980 ↗
24. 10.1038/nrcardio.2017.22410.1038/nrcardio.2017.224 ↗
25. 10.1002/advs.20200233010.1002/advs.202002330 ↗
26. 10.1016/j.biomaterials.2020.11990410.1016/j.biomaterials.2020.119904 ↗
27. 10.1016/j.biomaterials.2023.12231110.1016/j.biomaterials.2023.122311 ↗
28. 10.1016/j.jconrel.2020.02.00210.1016/j.jconrel.2020.02.002 ↗
29. 10.1002/adfm.20221126710.1002/adfm.202211267 ↗
30. 10.1021/acscatal.3c0222010.1021/acscatal.3c02220 ↗
31. 10.1016/j.ccr.2022.21464910.1016/j.ccr.2022.214649 ↗
32. 10.1002/adfm.20221502210.1002/adfm.202215022 ↗
33. 10.1016/j.compositesb.2022.10966510.1016/j.compositesb.2022.109665 ↗
34. 10.1038/s41586-021-04068-z10.1038/s41586-021-04068-z ↗
35. 10.1021/jacs.1c0901810.1021/jacs.1c09018 ↗
36. 10.1016/j.powtec.2022.11732710.1016/j.powtec.2022.117327 ↗
37. 10.1039/D1CS01165K10.1039/D1CS01165K ↗
38. 10.1039/D0MH01317J10.1039/D0MH01317J ↗
39. 10.1021/acs.chemmater.6b0158710.1021/acs.chemmater.6b01587 ↗
40. 10.3390/nu1102047410.3390/nu11020474 ↗
41. 10.1016/j.saa.2005.10.01310.1016/j.saa.2005.10.013 ↗
42. 10.1016/j.msec.2021.11253510.1016/j.msec.2021.112535 ↗
43. Ibrahim M. · Indian J. Pure & Appl. Phys. · 2005 · 34 · 911
44. 10.1021/cr400083y10.1021/cr400083y ↗
45. 10.1016/j.pharmthera.2022.10831510.1016/j.pharmthera.2022.108315 ↗
46. 10.1002/adfm.20221399310.1002/adfm.202213993 ↗
47. 10.1038/s41392-022-00955-710.1038/s41392-022-00955-7 ↗
48. 10.1038/s41581-019-0110-210.1038/s41581-019-0110-2 ↗
49. 10.1038/s41392-018-0006-910.1038/s41392-018-0006-9 ↗
50. 10.1016/j.biopha.2020.11066010.1016/j.biopha.2020.110660 ↗
51. 10.1038/s41577-023-00856-y10.1038/s41577-023-00856-y ↗
52. 10.1159/00045780210.1159/000457802 ↗
53. 10.1002/adma.20220197110.1002/adma.202201971 ↗
54. 10.1093/cvr/cvz07410.1093/cvr/cvz074 ↗